RecruitingPhase 3NCT06625957

Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 in Patients Who Require Parenteral Nutrition

A Randomized, Open-labeled, Multi-center, Active-controlled, Parallel-group Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 Versus NTCB-C in Patients Who Require Parenteral Nutrition

Sponsor

Yuhan Corporation

Enrollment

60 participants

Start Date

Dec 4, 2024

Study Type

INTERVENTIONAL

Conditions

parenteral nutrition

Summary

A Randomized, Open-labeled, Multi-center, Active-controlled, Parallel-group Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 versus NTCB-C in patients who require parenteral nutrition

Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called NTCB-C and a drug called NTCB02-1 for people with parenteral nutrition. The study is currently recruiting participants at 5 locations. People eligible for this study include aged 19 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGNTCB02-1

3 Days infusion

DRUGNTCB-C

3 Days infusion

Locations(5)

National Cancer Center

Gyeonggi-do, Goyang-si, South Korea

Chonnam National University Hwasun Hospital

Jeollanam-do, Hwasun-gun, South Korea

Jeonbuk National University Hospital

Jeollabuk-do, Jeonju-si, South Korea

Severance Hospital

Seoul, Seodaemun-gu, South Korea

Seoul National University Bundang

Gyeonggi-do, Seongnam-si, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06625957

Related Trials

AGE Accumulation in Patients on Long-term Parenteral Nutrition

NCT073928013 locations

Weaning is Winning? (WeWin Study)

NCT065257531 location

Achieving nuTritional Target in criticAlly Ill patieNts With iMpairEd gastroiNtesTinal Dysfunction

NCT065103481 location